Table 5.
Revision and complications.
| Study | Number followed | Follow-up (mo) | Revision | Infection | Infection revision | Dislocation | Dislocation/instability revision | Aseptic loosening revision | Acetabular loosening revision | Femoral loosening revision | Sciatic nerve palsy |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nicol 2021 [19] | 14 | 60 ± 48 | 3 | 1 | 1 | NA | 0 | 1 | 1 | 0 | NA |
| Lucchini 2021 [20] | 68 | 142 ± 19.2 (122–212) | 8 | 0 | 0 | 2 | 0 | 2 | 0 | 2 | NA |
| Kumar 2021 [21] | 18 | 28 (12-60) | 0 | 1 | 0 | NA | 0 | 0 | 0 | 0 | NA |
| Kassem 2021 [22] | 45 | 124 (84-180) | 2 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 1 |
| Gracia 2021 [23] | 39 | 70 (24-132) ORIF 50 Cons 90 | 7 | 4 ORIF 2 Cons 2 | 4 ORIF 2 Cons 2 | 1 ORIF 1 | 0 | 2 ORIF 1 Cons 1 | NA | NA | 1 ORIF 1 |
| Rezaie 2020 [13] | 72 | 35 (12-146) | NA | 5 | NA | NA | NA | NA | NA | NA | 6 |
| Moon 2020 [24] | 37 | 79 (24-145) | 4 | 3 | 2 | 3 | 1 | 1 | 1 | 0 | NA |
| Busch 2020 [25] | 48 | 54 ± 23 (14–88) | 8 | 1 | 1 | NA | 1 | 5 | 4 | 1 | NA |
| Garcia Rey 2020 [26] | 78 | 133 (60-276) ORIF 122 Cons 140 | 6 ORIF 3 Cons 3 | 0 | 0 | 2 ORIF 1 Cons 1 | 0 | 6 ORIF 3 Cons 3 | 5 ORIF 3 Cons 2 | 1 Cons 1 | NA |
| Do 2020 [27] | 25 | 50 (24-222) | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | NA |
| Dawson 2019 [4] | 25 | 22 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taheriazam 2019 [28] | 49 | 44 (24-60) | NA | 2 | 2 | 0 | 0 | NA | NA | NA | 0 |
| Lee 2019 [29] | 57 | 94 ± 29 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Wang 2018 [30] | 33 | 138 ± 36 (96-204) | 3 ORIF 2 Cons 1 | 1 ORIF1 | 1 ORIF 1 | 1 ORIF 1 | 0 | 0 | 0 | 0 | 0 |
| Salama 2017 [31] | 21 | 26 (24–36) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NA |
| Clarke-Jensson 2017 [32] | 52 | Median 88 (12-252) | 11 | 3 | 3 | 4 | 4 | 2 | 2 | 0 | NA |
| Gavaskar 2017 [33] | 44 | ORIF 82 ± 117 Cons 85 ± 16 | 3 ORIF 1 Cons 2 | 1 ORIF1 | 1 ORIF1 | 2 ORIF 1 Cons 1 | 1 Cons 1 | 1 Cons 1 | 1 Cons 1 | 0 | 2 Cons 2 |
| Morison 2016 [34] | 74 | 120 (24-288) | 24 ORIF 21 Cons 3 | 5 | 2 | 8 | 7 | NA | 13 ORIF 2 Cons 11 | 1 | 1 |
| Yuan 2015 [35] | 28 | 60 (25-120) | 3 | 3 | 3 | 2 | 0 | 0 | 0 | 0 | 0 |
| Chiu 2015 [36] | 56 | 120 (60-180) | 3 | 3 | 0 | NA | 0 | 3 | 3 | 0 | NA |
| Schnaser 2014 [37] | 17 | 77 ± 33 | 1 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | NA |
| Lizaur Utrilla 2012 [38] | 24 | 101 (60-180) | 4 | 1 | 1 | 1 | 1 | 2 | 2 Cons 2 | 1 Cons 1 | 0 |
| Lai 2011 [39] | 31 | 76 (37–101) | 0 | 0 | 0 | 2 ORIF 1 Cons 1 | 0 | 0 | 0 | 0 | 1 ORIF 1 |
| Zhang 2011 [40] | 51 | 64 (32-123) | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 3 |
| Ranawat 2009 [12] | 32 | 59 (48-116) | 6 | 6 ORIF 4 Cons 2 | 2 | 3 | 1 | 3 | 1 | 2 | NA |
| Bellabarba 2001 [41] | 30 | 63 (24-140) | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | NA |
| Sarkar 2001 [42] | 22 | 48 (15-168) | 10 | 2 | 2 | 2 | 4 | 3 | 1 | 2 | NA |
| Huo 1999 [43] | 21 | 65 (48-104) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Weber 1998 [44] | 63 | 115 (24–240) | 17 | 0 | 0 | 0 | 1 | 16 | 9 | 10 | 1 |